Only if/when the virus is involved in causation and/or perpetuation.
That goes without saying.
But since ME/CFS is often seen to appear immediately after viral infection, since enterovirus has been strongly associated with ME/CFS in numerous studies (not just in Dr Chia's), since ME/CFS symptoms often get better after interferon or oxymatrine treatments (along with a concomitant viral reduction in enteroviral load), and since when relapse occurs after discontinuation of these treatments, viral load is also seen to rise again along with the worsening of symptoms, there is a good argument for assuming enterovirus is involved in causation and perpetuation.
Oh and I forgot to mention that three separate brain autopsy studies all found an enterovirus infection in the brain of ME/CFS patients, but no such infection in healthy controls.
All good evidence to support the idea that enterovirus plays a causal role.
If we examine these remissions and improvements from an autoimmune angle, one might speculate that, as an alternative hypothesis, interferon and oxymatrine may be improving ME/CFS by ameliorating some underlying autoimmunity, rather than by reducing viral load.
However, from what I can gather, both interferon and oxymatrine have a tendency of
triggering rather than ameliorating autoimmunity. For example, in hepatitis C patients receiving interferon treatment, 4% to 19% of these patients will go on to develop autoimmune conditions like lupus. Ref:
1
And Dr Chia himself has observed how oxymatrine can trigger rheumatoid arthritis in some ME/CFS patients.
So it seems unlikely that interferon and oxymatrine treat ME/CFS by reducing autoimmunity. Although if enterovirus were driving the autoimmune processes in ME/CFS, as some believe this virus does in type 1 diabetes, then the reduction in enteroviral load interferon and oxymatrine achieve in ME/CFS may indirectly lead to amelioration in autoimmunity.
It would be interesting to see if measurements of autoimmunity (such as autoantibody production) go down after interferon treatment in enterovirus-associated ME/CFS.